Evidence map›Paper›PMID 26673666›Full record

ArticleCell death & disease2015

Cigarette toxicity triggers Leber's hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways.

L Giordano, S Deceglie, P d'Adamo, M L Valentino, C La Morgia, F Fracasso, M Roberti, M Cappellari, G Petrosillo, S Ciaravolo and 13 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 126 citations in OpenAlex.

  1. [Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Review
  2. Article
  3. Review
  4. [Pathogenic mechanisms of Leber hereditary optic neuropathy caused by m.3472T>C mutation].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 3 countries.

L GiordanoDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
S DeceglieDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
P d'AdamoDepartment of Reproductive Sciences, Medical Genetics, Development and Public Health, University of Trieste, Trieste, Italy.
M L ValentinoIRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy.
C La MorgiaIRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy.
F FracassoDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
M RobertiDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
M CappellariDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
G PetrosilloInstitute of Biomembranes and Bioenergetics (IBBE) National Research Council (CNR), Bari, Italy.
S CiaravoloVectis s.r.l. Cava dei Tirreni (Salerno), Italy.
D ParenteVectis s.r.l. Cava dei Tirreni (Salerno), Italy.
C GiordanoDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.
A MarescaIRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy.
L IommariniIRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy.
V Del DottoDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
A M GhelliDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
S R SalomaoDepartment of Ophthalmology, and Visual Sciences, Paulista School of Medicine Federal University of Sao Paulo-UNIFESP, Sao Paulo, Brazil.
A BerezovskyDepartment of Ophthalmology, and Visual Sciences, Paulista School of Medicine Federal University of Sao Paulo-UNIFESP, Sao Paulo, Brazil.
R BelfortDepartment of Ophthalmology, and Visual Sciences, Paulista School of Medicine Federal University of Sao Paulo-UNIFESP, Sao Paulo, Brazil.
A A SadunDoheny Eye Institute, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
V CarelliIRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy.
P Loguercio PolosaDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
P CantatoreDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
University of Bari Aldo Moro · ITUniversity of Bologna · ITUniversidade Federal de São Paulo · BRIstituti di Ricovero e Cura a Carattere Scientifico · ITDoheny Eye Institute · USInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITInstitute of Neurological Sciences · ITNational Research Council · ITSapienza University of Rome · ITUniversity of Trieste · IT

Funding

Telethon GGP11182Telethon GGP14187
6 · The paper itself

Abstract

Leber's hereditary optic neuropathy (LHON), the most frequent mitochondrial disease, is associated with mitochondrial DNA (mtDNA) point mutations affecting Complex I subunits, usually homoplasmic. This blinding disorder is characterized by incomplete penetrance, possibly related to several genetic modifying factors. We recently reported that increased mitochondrial biogenesis in unaffected mutation carriers is a compensatory mechanism, which reduces penetrance. Also, environmental factors such as cigarette smoking have been implicated as disease triggers. To investigate this issue further, we first assessed the relationship between cigarette smoke and mtDNA copy number in blood cells from large cohorts of LHON families, finding that smoking was significantly associated with the lowest mtDNA content in affected individuals. To unwrap the mechanism of tobacco toxicity in LHON, we exposed fibroblasts from affected individuals, unaffected mutation carriers and controls to cigarette smoke condensate (CSC). CSC decreased mtDNA copy number in all cells; moreover, it caused significant reduction of ATP level only in mutated cells including carriers. This implies that the bioenergetic compensation in carriers is hampered by exposure to smoke derivatives. We also observed that in untreated cells the level of carbonylated proteins was highest in affected individuals, whereas the level of several detoxifying enzymes was highest in carriers. Thus, carriers are particularly successful in reactive oxygen species (ROS) scavenging capacity. After CSC exposure, the amount of detoxifying enzymes increased in all cells, but carbonylated proteins increased only in LHON mutant cells, mostly from affected individuals. All considered, it appears that exposure to smoke derivatives has a more deleterious effect in affected individuals, whereas carriers are the most efficient in mitigating ROS rather than recovering bioenergetics. Therefore, the identification of genetic modifiers that modulate LHON penetrance must take into account also the exposure to environmental triggers such as tobacco smoke.

Indexed as

DNA, MitochondrialFemaleHumansMaleOptic Atrophy, Hereditary, LeberOxidative PhosphorylationReactive Oxygen SpeciesSmokingDNA, MitochondrialReactive Oxygen Species

Identifiers

PMID26673666
PMCPMC4720897
OpenAlexW2198724960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.